DBV Technologies | Lucro Bruto Sobre Vendas



Gross Profit On Sales Alterar Data
Acadia Pharmaceuticals USD 223.92M 13.87M 2025-03
Alnylam Pharmaceuticals USD 630.74M 107.59M 2025-06
Amarin USD 25.13M 1.78M 2025-03
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
DBV Technologies -30442000 30.56M 2024-09
Halozyme Therapeutics USD 216.46M 39.49M 2025-03
Incyte USD 1.14B 151.67M 2025-06
Insmed USD 71.54M 6.75M 2025-03
Ionis Pharmaceuticals USD 448M 317.85M 2025-06
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
PTC Therapeutics USD 196.89M 10.95M 2024-12
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
United Therapeutics USD 711M 9.1M 2025-06


DBV Technologies Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.